Why Envoy Medical, Inc.’s (COCH) Stock Is Up 5.41%
As of Tuesday, November 03, Envoy Medical, Inc.’s COCH share price has surged by 5.41%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Michael Rose
Cynthia McLaughlin
Michael Rose
Jenna Brashear
| Share Statistics | COCH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $51.9 | $356.4 | 18% |
|
| Shares Out (Mil) | 10.4 | 41.2 | 21% |
|
| Institutional Ownership | 30.6% | 83.1% | 12% |
|
| Float (Mil) | 4.3 | 36.7 | 11% |
|
| Beta | 2.02 | 0.89 | 92% |
|
| Avg Daily Volume (000s) | 36 | 318 | 26% |
|
| Price Change (52-week) |
(12.5%) | 55.9% | 42% |
|
| Growth | COCH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | ($0.653) | ($2.623) | ($2.437) | |
| Month Ago EPS | ($0.700) | ($2.867) | ($2.367) | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | ($0.750) | ($3.100) | ($2.250) | |
| Year/Year Chg | 30.1% | (78.7%) | (80.7%) | |
| Financials | COCH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $123 | 0% |
|
| Net Income (TTM) (Mil) | ($21) | ($9) | 23% |
|
| EPS (TTM) | ($3.390) | ($0.300) | 10% |
|
| Operating Cash Flow (TTM) (Mil) | ($22) | ($1) | 14% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $1 | $21 | 15% |
|
| Enterprise Value (Q1) (Mil) | $40 | $381 | 16% |
|
| Valuation | COCH | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.46 | na |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | COCH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (270.6%) | 59.1% | 1% |
|
| Net Margin | na | (4.6%) | na |
|
| ROA | (152.5%) | (9.9%) | 3% |
|
| ROE | 480.9% | (8.5%) | 99% |
|
| Liabilities to Assets | 106.0% | 45.6% | 95% |
|
| F-Score | 4 | 4 | 34% |
|
Envoy Medical, Inc. did not pass any screens on 11/19/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors